Spyre Therapeutics Inc (NAS:SYRE)
$ 86.64 -2.26 (-2.54%) Market Cap: 7.52 Bil Enterprise Value: 6.94 Bil PE Ratio: 0 PB Ratio: 13.26 GF Score: 31/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1